Wikipedia -WSS

Wikipedia

author：entertainment 2025-10-01 17:20:26 - browse：324

Hyacinth Empinado/STAT

The body mass index, or BMI, is the formula that’s used most often to diagnose overweight and obesity. But unlike other common diagnoses, there is a certain stigma applied to people with a high body mass index, or BMI, which can affect how they are perceived by peers, providers, and society at large.

Despite the ubiquity of the BMI in medicine, many argue that it is a flawed tool, with a strange history. In recent months, the BMI has become more relevant than ever as the new semaglutide weight loss drugs are poised to change how obesity is understood and treated.

BMI is a simple calculation — a person’s weight in kilograms divided by the square of their height. But how BMI is then translated into a diagnosis is complicated and flawed.

Related: New weight loss drugs are changing the narrative on obesity, with a push from pharma

Watch this video to learn more about the history of the BMI — how it became so entrenched in medicine and, surprisingly, how its introduction may have set back decades of work on how obesity contributes to disease.

A STAT series is examining new obesity drugs that are transforming patients’ lives, dividing medical experts, and spurring one of the biggest business battles in years. Read more about The Obesity Revolution.

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： STAT Summit: Doctor v. ChatGPT showed AI's promise, blind spots

focus

WSS

FDA clears Verve to begin U.S. study of gene

STAT Readout: Friday, Oct. 20 biotech updates

Study on Amgen’s bispecific immunotherapy produces positive data

Harvard's Jason Buenrostro wins MacArthur grant for genetics work

I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

STAT Summit: How researchers deal with rejection

focus

Wikipedia

Related: New weight loss drugs are changing the narrative on obesity, with a push from pharma

hotspot

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Merck, Daiichi strike cancer drug pact worth up to $22 billion

Medicare details structure of new drug price negotiation program

AstraZeneca to buy developer of next

ChatGPT in medicine: STAT answers readers' burning questions

U.K. not yet recommending Vertex's CRISPR therapy for sickle cell

Hollywood unions extend contract negotiations for actors

Roivant's CEO is a star, but biotech's black hole persists

In age of alternative facts, a scholarly course on calling out crap

I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

hotspot

How AI can help patients find reliable information about doctors

STAT Readout: Friday, Oct. 20 biotech updates

STAT Summit: Ending the crisis of Black deaths in the U.S.

STAT Summit: Ending the crisis of Black deaths in the U.S.

Colonoscopy prep: Liquid

FDA clears Verve to begin U.S. study of gene

leisure time

focus

hotspot

knowledge